BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16712600)

  • 21. Tissue Doppler imaging for rejection surveillance in pediatric heart transplant recipients.
    Lunze FI; Colan SD; Gauvreau K; Perez-Atayde AR; Smith RN; Blume ED; Singh TP
    J Heart Lung Transplant; 2013 Oct; 32(10):1027-33. PubMed ID: 23937884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NTproBNP as a marker of rejection in pediatric heart transplant recipients.
    Knecht KR; Alexander ML; Swearingen CJ; Frazier EA
    Pediatr Transplant; 2012 Jun; 16(4):335-9. PubMed ID: 22429516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved Detection of Cardiac Allograft Vasculopathy: A Multi-Institutional Analysis of Functional Parameters in Pediatric Heart Transplant Recipients.
    Kindel SJ; Law YM; Chin C; Burch M; Kirklin JK; Naftel DC; Pruitt E; Carboni MP; Arens A; Atz AM; Dreyer WJ; Mahle WT; Pahl E
    J Am Coll Cardiol; 2015 Aug; 66(5):547-57. PubMed ID: 26227194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of Diastolic Strain Measurements in Predicting Elevated Left Ventricular Filling Pressure and Risk of Rejection or Coronary Artery Vasculopathy in Pediatric Heart Transplant Recipients.
    Lu JC; Magdo HS; Yu S; Lowery R; Aiyagari R; Zamberlan M; Gajarski RJ
    Am J Cardiol; 2016 May; 117(9):1533-8. PubMed ID: 26976792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble inflammatory markers in coronary sinus and peripheral blood of heart transplant recipients.
    Hsu RB; Tsay YG; Lee CM; Chen RJ; Wang SS; Chu SH
    Clin Transplant; 2003 Aug; 17(4):331-7. PubMed ID: 12868989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue Doppler imaging detects severely abnormal myocardial velocities that identify children with pre-terminal cardiac graft failure after heart transplantation.
    Fyfe DA; Ketchum D; Lewis R; Sabatier J; Kanter K; Mahle W; Vincent R
    J Heart Lung Transplant; 2006 May; 25(5):510-7. PubMed ID: 16678028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coagulation markers predicting cardiac transplant rejection.
    Segal JB; Kasper EK; Rohde C; Bray PF; Baldwin WM; Resar JR; Hruban RH; Kickler TS
    Transplantation; 2001 Jul; 72(2):233-7. PubMed ID: 11477344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronary flow reserve measurement detects transplant coronary artery disease in pediatric heart transplant patients.
    Schubert S; Abdul-Khaliq H; Wellnhofer E; Hiemann NE; Ewert P; Lehmkuhl HB; Meyer R; Miera O; Peters B; Hetzer R; Berger F
    J Heart Lung Transplant; 2008 May; 27(5):514-21. PubMed ID: 18442717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arrhythmias in pediatric heart transplant recipients: prevalence and association with death, coronary artery disease, and rejection.
    Park JK; Hsu DT; Hordof AJ; Addonizio LJ
    J Heart Lung Transplant; 1993; 12(6 Pt 1):956-64. PubMed ID: 8312320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of plasma B-type natriuretic peptide as a marker for rejection in pediatric heart transplant recipients.
    Lindblade CL; Chun DS; Darragh RK; Caldwell RL; Murphy DJ; Schamberger MS
    Am J Cardiol; 2005 Apr; 95(7):909-11. PubMed ID: 15781032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated ST2 levels are associated with antibody-mediated rejection in heart transplant recipients.
    Grupper A; AbouEzzeddine OF; Maleszewski JJ; Grupper A; Geske JR; Kremers WK; Kushwaha SS; Pereira NL
    Clin Transplant; 2018 Sep; 32(9):e13349. PubMed ID: 29998506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The presentation and diagnosis of coronary allograft vasculopathy in pediatric heart transplant recipients.
    Jeewa A; Dreyer WJ; Kearney DL; Denfield SW
    Congenit Heart Dis; 2012; 7(4):302-11. PubMed ID: 22497818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list; Implications for donor selection criteria.
    Lietz K; John R; Mancini DM; Edwards NM
    J Am Coll Cardiol; 2004 May; 43(9):1553-61. PubMed ID: 15120811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of longitudinal myocardial deformation by 2-dimensional speckle-tracking echocardiography in heart transplant recipients: relation to coronary allograft vasculopathy.
    Clemmensen TS; Løgstrup BB; Eiskjær H; Poulsen SH
    J Heart Lung Transplant; 2015 Feb; 34(2):195-203. PubMed ID: 25108908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronary plaque composition assessed by intravascular ultrasound virtual histology: association with long-term clinical outcomes after heart transplantation in young adult recipients.
    Tomai F; Adorisio R; De Luca L; Pilati M; Petrolini A; Ghini AS; Parisi F; Pongiglione G; Gagliardi MG
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):70-7. PubMed ID: 23765788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease?
    Radovancevic B; Golino A; Vrtovec B; Thomas CD; Radovancevic R; Odegaard P; van Rossem CC; Gaemers SJ; Vaughn WK; Smart FW; Frazier OH
    J Heart Lung Transplant; 2005 Jun; 24(6):703-7. PubMed ID: 15949730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of third heart transplants in pediatric and young adult patients: analysis of the United Network for Organ Sharing database.
    Friedland-Little JM; Gajarski RJ; Yu S; Donohue JE; Zamberlan MC; Schumacher KR
    J Heart Lung Transplant; 2014 Sep; 33(9):917-23. PubMed ID: 24861821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction.
    Zeitler H; Ko Y; Zimmermann C; Nickenig G; Glänzer K; Walger P; Sachinidis A; Vetter H
    Eur J Med Res; 1997 Sep; 2(9):389-94. PubMed ID: 9300936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronary artery disease in pediatric cardiac transplant recipients receiving triple-drug immunosuppression.
    Braunlin EA; Hunter DW; Canter CE; Gutierrez FR; Ring WS; Olivari MT; Titus JL; Spray TL; Bolman RM
    Circulation; 1991 Nov; 84(5 Suppl):III303-9. PubMed ID: 1657452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation.
    Arora S; Gullestad L; Wergeland R; Simonsen S; Holm T; Hognestad A; Ueland T; Geiran O; Andreassen A
    Transplantation; 2007 May; 83(10):1308-15. PubMed ID: 17519779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.